Skip to main content
logo
INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.130
-0.045 (-3.83%)
At close: Nov 6, 2026, 4:00 PM EST
1.029
-0.101 (-8.97%)
After-hours: Nov 6, 2026, 7:58 PM EST

INmune Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-16.67-45.93-42.08-30.01-27.3-30.34
Depreciation & Amortization
0.250.08----
Other Amortization
--0.080.220.240.13
Asset Writedown & Restructuring Costs
-16.51--0.09-
Stock-Based Compensation
7.39.917.617.377.154.8
Other Operating Activities
-0.09-0.63----
Change in Accounts Payable
-4.581.86-1.372.721.42.26
Change in Other Net Operating Assets
0.89-4.392.417.72-4.27-5.35
Operating Cash Flow
-12.91-22.58-33.36-11.98-22.69-28.5
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.57-1.04----
Other Investing Activities
------15
Investing Cash Flow
-0.57-1.04----15

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-----14.95
Total Debt Issued
-----14.95
Long-Term Debt Repaid
---10-5--
Net Debt Issued (Repaid)
---10-5-14.95
Issuance of Common Stock
2.0827.5528.210.780.7381.41
Other Financing Activities
0.070.07----
Financing Cash Flow
2.1427.6118.21-4.230.7396.36

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.06-0.160.22-0.1-0.7-0.01
Net Cash Flow
-11.413.83-14.93-16.31-22.6652.84

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-13.49-23.62-33.36-11.98-22.69-28.5
Free Cash Flow Growth
------
Free Cash Flow Margin
--47248.00%-238292.86%-7729.03%-6065.77%-15748.07%
Free Cash Flow Per Share
-0.50-0.95-1.67-0.67-1.26-1.77
Levered Free Cash Flow
-5.64-13.03-18.45-1.4-13.27-16.53
Unlevered Free Cash Flow
-5.64-13.03-18.03-0.2-12.25-16.66

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--1.691.781.370.56
Change in Working Capital
-3.7-2.531.0410.44-2.86-3.09
SEC Filings: 10-K · 10-Q